explore -WSS

explore

author：explore 2025-09-28 02:29:49 - browse：379

Nuance Image Gallery

Microsoft on Thursday said it will launch its artificial intelligence tool for automating clinical documentation within health records software made by Epic, a move to embed the technology in health systems nationwide.

The AI product, DAX Copilot, will automatically draft notes through Epic’s mobile application, known as Haiku, making it available for immediate review by clinicians. The tool is designed to streamline clinician note taking, a laborious process that has become a common source of complaint within health systems.

DAX Copilot is already used by hundreds of hospitals and clinics, but its availability through Epic significantly expands its reach and availability to potential users. Epic is the nation’s largest seller of software used to record and analyze patient health records.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hollywood unions extend contract negotiations for actors
Next article： How one medical school became remarkably diverse

hotspot

WSS

BioMarin wins approval for gene therapy to treat hemophilia A

Walensky prepares to leave CDC — and Congress — behind

Meadows told special counsel he could not recall Trump ever declassifying Mar

Psychedelics group wrestles with new pharma identity

DIEP, the 'gold standard' of breast reconstruction, is under threat

FDA approval of Sarepta Duchenne genetic therapy gives me hope

hotspot

explore

explore

Medical leaders decry Supreme Court decision on affirmative action

Listen: Vivek Ramaswamy's star turn & leaky drug data

The cancer drug shortage isn’t new — and neither are the solutions

Roche's accidental data boosts hopes for anti

At least 13 dead in Texas as scorching temps continue

How to make over

Peter Hotez and the public health issue of online harassment

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

BioMarin wins approval for gene therapy to treat hemophilia A

CDC says it’s too soon to assess risk posed by Covid subvariant

focus

23andMe had bad news about my health. I wish a person had delivered it

Drugmakers bet big on mRNA for cancer. Why's Biden going in?

Drug repurposing or repositioning? The language matters

Kellogg’s is going to war over Mexico’s nutrition label rules

Abortion policy in the spotlight at Republican debate

FDA advisory panel to debate high blood pressure devices

focus

hotspot

leisure time

focus